At the meeting of Haemophilia directors, officials and haemophilia centre directors from across Scotland a comment was recorded as being made by Dr Henry Watson of Aberdeen Haemophilia Centre that the clinician "would have to make the decision of whether to hand the patient a host of information or outline the benefits/risks of particular products."